RecallRadar

FDA Drug recall D-0461-2021

Valsartan Tablets USP 40 mg 30 Scored Tablets Rx Only NDC 59746-360-30 Manufactured by: Jubilant Generics Ltd

On 2021-06-02 the FDA classified a Class II recall of Valsartan Tablets USP 40 mg 30 Scored Tablets Rx Only NDC 59746-360-30 Manufactured by: Jubilant Generics Ltd by Cardinal Health, citing CGMP Deviations: Intermittent exposure to temperature excursion during storage.

Read the official FDA Drug notice

AgencyFDA Drug
Recall numberD-0461-2021
ClassificationClass II
Statusterminated
Initiated2021-03-15
Published2021-06-02
Last updated2026-09-13 11:52 UTC
CompanyCardinal Health
DistributionFL, GA, SC

Product

Valsartan Tablets USP 40 mg 30 Scored Tablets Rx Only NDC 59746-360-30 Manufactured by: Jubilant Generics Ltd. Roorkee-247661, India

Reason

CGMP Deviations: Intermittent exposure to temperature excursion during storage.

Identifiers

ndc59746-360-30
ndc59746-360-90
ndc59746-360-05
ndc59746-360-03
ndc59746-361-30
ndc59746-361-90
ndc59746-361-05
ndc59746-361-03
ndc59746-362-30
ndc59746-362-90
ndc59746-362-05
ndc59746-362-03
ndc59746-393-30
ndc59746-393-90
ndc59746-393-67
ndc59746-393-32
code_infoVR120022A

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: terminated.

Source

Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0461-2021%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.